Valvular Heart Disease Registry Focusing on Gender Differences
Official title: Valvular Heart Disease in Women Registry
Run by Valvular Heart Disease in Women Registry · NCT07196930 · Data updated 2026-11-12
This registry will track care and outcomes for adults with valvular heart disease to see if there are gender differences from hospital admission through the first outpatient follow-up.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Valvular Heart Disease in Women Registry Research network |
| Locations | 2 sites (Aswān and 1 other locations) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | December 2027 |
| Study ends | December 2030 |
| Registry record updated | September 29, 2025 |
| Trial ID | NCT07196930 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 years or older with any valvular heart disease per current ESC guidelines who are admitted to a participating registry center and can provide informed consent are eligible.
✕Probably not a fit
People under 18, those unable to give informed consent, and patients not treated at participating centers are not eligible and are unlikely to receive direct benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter observational registry that will enroll adults admitted with any valvular heart disease as defined by current ESC guidelines and collect clinical, diagnostic, treatment, and follow-up data. Data will be gathered from the point of hospital admission (elective or urgent) through the first outpatient clinic visit to capture pathways of care and guideline adherence. The registry will analyze differences by gender in diagnosis, use of therapies, and early outcomes, without altering patient care. The European Association of Cardiovascular Imaging is a listed collaborator, and participating sites include centers such as Aswan Heart Centre and the University of Lisbon.
Why it matters
Potential benefit: If successful, the registry could identify gaps in diagnosis and treatment that lead to more equitable, guideline-based care for patients with valvular heart disease.
How similar studies have gone: Previous valvular heart disease registries and cardiovascular databases have documented gender-based gaps in care, though dedicated multinational registries focused on women remain relatively limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients with diagnosis of any VHD according to the current ESC guidelines. * Admission to the VHD-W Registry collaborating center. Exclusion Criteria: * Age less than 18 years old. * Inability to provide informed consent per local institutional and regulatory requirements.
Where it's running
-
Aswan Heart Centre
Aswān, Egypt Recruiting -
University of Lisbon
Lisbon, Portugal Recruiting
Study contacts
- Principal investigator: Julia Grapsa, MD PhD — Harvard Medical School (HMS and HSDM)
- Study coordinator: Shehab Anwer, MD
- Email: shehab.anwer@gmail.com
- Phone: +41788816333
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nonintubated anesthesia for adults undergoing cardiac surgery with bypass
This trial tests a nonintubated airway approach with the goal of seeing if avoiding endotracheal intubation during elective valve or bypass surgery can reduce lung problems and help patients recover faster.
-
Guideline Adherence in HFrEF: See If Mirror Information Helps Doctors and Patients Follow GDMT
This study tests whether showing doctors, or both doctors and patients, mirror information about how well guideline-directed medical therapy is being used in heart failure with reduced ejection fraction.
-
Physiotherapy practices for residents in Flemish nursing homes.
This project will see how physiotherapists in Flemish nursing homes follow the IAGG-GARN physiotherapy guidelines and what helps or gets in the way.
-
HemoCept device data collection during diagnostic right heart catheterization
This pilot will collect HemoCept device readings from adults having diagnostic right heart catheterization to see how the device records heart pressures.
-
UK islet autoantibody registry for early Type 1 diabetes
This UK registry collects health and antibody information from people with one or more islet autoantibodies to track who develops Type 1 diabetes and to connect them with monitoring or prevention options.
-
Asia‑Pacific registry of mitral and tricuspid valve‑in‑valve and valve‑in‑ring procedures
Collecting medical data from adults across the Asia‑Pacific who have had—or plan to have—mitral or tricuspid valve‑in‑valve or valve‑in‑ring procedures with a balloon‑expandable valve to see how patients do.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.